Browsing Category

63345 posts
LifeZoom Launches Veyra, a Lightweight Curved Red Light Device for Stand, Belt, and Dome-Style Use

LifeZoom Launches Veyra, a Lightweight Curved Red Light Device for Stand, Belt, and Dome-Style Use

NEW YORK, July 15, 2026 /PRNewswire/ — LifeZoom today announced the launch…

Fusion CX Receives Frost & Sullivan's 2026 North America Customer Value Leadership Recognition for Excellence in Customer Experience Transformation

Recognized for innovation, customer success, and AI-driven omnichannel customer experience management, delivering…
XGIMI Redefines Portable Projection with the Expanded Elfin Flip Series, Led by the Elfin Flip 4K — Its Flagship Portable 4K Laser Projector

XGIMI Redefines Portable Projection with the Expanded Elfin Flip Series, Led by the Elfin Flip 4K — Its Flagship Portable 4K Laser Projector

The new Elfin Flip Series ends the trade-off between portability and performance…

Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board

Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to…
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases,…
NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report

NYSE Content Update: Women's Health Equity Funding Up 41% in 2025 Report

NYSE issues a pre-market daily advisory direct from the trading floor. NEW…
Dao by Dorsett AMTD Singapore Honoured with Tripadvisor Travellers' Choice 2026, Recognised Among the Top 10% of Properties Worldwide

Dao by Dorsett AMTD Singapore Honoured with Tripadvisor Travellers' Choice 2026, Recognised Among the Top 10% of Properties Worldwide

PARIS and NEW YORK and LONDON, July 15, 2026 /PRNewswire/ — AMTD…
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS

Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS

— Peer-reviewed publication details RAG-17’s robust translation from "bench to bedside," validating…